LSL Pharma Group Stock Price

TSXV:LSLCA$45.6mHousehold

LSL Share Price Performance

LSL Community Fair Values

Your Fair Value
CA$
Current Price
CA$0.4041.1% overvalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent LSL News & Updates

Shareholders Should Be Pleased With LSL Pharma Group Inc.'s (CVE:LSL) Price

May 02

LSL Pharma Group Inc. Competitors

View more competitors

LSL Pharma Group Inc. Key Details

Last Reported Earnings

Dec 31, 2024

Yearly revenue growth

n/a

Earnings per share (EPS): 0.029
Gross Margin: 30.13%
Net Profit Margin: 18.69%
Debt/Equity Ratio: 67.3%

View full report ›

Canadian Market Performance

7 Days: 0.4%
3 Months: 10.0%
1 Year: 16.5%
Year to Date: 6.2%

The market has been flat over the last week. As for the longer term, the market has risen 16% in the past 12 months. Looking forward, earnings are forecast to grow by 13% annually. Market details ›

🚀 Finding Moonshots in the Space Race

Richard Bowman

June 2025

The Space industry has a massive runway ahead of it, so it’s worth getting to know it if you are a long-term investor. We figured now would be a great time to check in on the industry!

Last Week

LSL Pharma Group Stock Price

LSL Share Price Performance

LSL Community Fair Values

Recent LSL News & Updates

New major risk - Financial position

Shareholders Should Be Pleased With LSL Pharma Group Inc.'s (CVE:LSL) Price

LSL Pharma Group Inc., Annual General Meeting, Jun 27, 2025

LSL Pharma Group Appoints Louis Laflamme to the Board of Directors

New major risk - Shareholder dilution

LSL Pharma Group Inc. announced that it has received CAD 1 million in funding

LSL Pharma Group Inc. (TSXV:LSL) acquired Dermolab Pharma Ltd. for CAD 4 million.

LSL Pharma Group Inc. Appoints Guy Paul Allard as Corporate Secretary

LSL Pharma Group Inc. Competitors

🚀 Finding Moonshots in the Space Race

🎢 Opportunities In The Turbulent Transition To Greener Energy